High amyloid levels linked to early-stage Alzheimer’s
By
Alicia Lasek
Apr 06, 2020
Screening data from an Alzheimer’s drug trial suggests that higher brain amyloid levels exist well before clinical symptoms appear.
Alzheimer’s discoveries show new promise for drug development, expert says
By
Alicia Lasek
Jul 20, 2020
The discovery of new biomarkers — along with a focus on repurposed drugs — are optimistic signs for Alzheimer’s research, according to a five-year analysis.
Time from infection to COVID symptoms shortens with each new variant, study finds
By
Alicia Lasek
Aug 24, 2022
The average incubation period of SARS-CoV-2 has gradually shortened, from 5 days to 3.4. Determining incubation periods can help to pinpoint effective patient isolation periods, investigators say.
Feds halt an Eli Lilly antibody therapy in 3 states due to variant fears, while boosting the treatment...
By
Alicia Lasek
Mar 19, 2021
A COVID-19 variant circulating widely in California, Arizona and Nevada has rendered bamlanivimab alone ineffective, an FDA official reports. But Lilly says an approved alternative treatment “maintains...
Clinical briefs for Wednesday, Dec. 1
By
Alicia Lasek
Dec 01, 2021
Regeneron’s COVID-19 antibody drug may be less effective against omicron, drugmaker says … Pandemic taking toll on healthcare workers’ sleep patterns … Ambulance staffing shortage frustrating nursing...
ADHD linked to Alzheimer’s disease across generations, scientists say
By
Alicia Lasek
Sep 14, 2021
Parents of children diagnosed with attention deficit hyperactivity disorder are more likely to receive a diagnosis of Alzheimer’s than their peers whose children do not have the condition, investigators...
Feds gauging threat to vaccine, test and treatment efficacy in face of omicron variant
By
Alicia Lasek
Dec 01, 2021
The United States is prepared to address any potential threat to the effectiveness of COVID-19 vaccines, tests and treatments posed by the new variant, according to the White House and federal health officials.
Alzheimer’s origin story is about metabolism and lifestyle, scientists contend
By
Alicia Lasek
Apr 02, 2021
Alzheimer’s Disease is increasingly being referred to as insulin resistance of the brain, or Type 3 diabetes, a research team says.
Blood tests that confirm Alzheimer’s disease expected soon
By
Alicia Lasek
Jul 16, 2019
A path to quicker and easier diagnosis seems near. Blood tests have the potential to replace costly and intrusive diagnostics.
Diet may help preserve cognition: Fish, vegetables most protective foods
By
Alicia Lasek
Apr 14, 2020
Study participants who consumed the most fish had a significantly slower cognitive decline rate, according to researchers.